Skin microvascular reactivity in patients with diabetic retinopathy.

Aims: Early detection of microangiopathic complications of diabetes mellitus (DM) is necessary to analyze the patient's condition and prevent disease progression. The study was aimed to investigate the relationship between the presence of retinopathy and decreased reactivity of the microcirculatory bed in patients with diabetes.

Methods: The study involved 130 subjects: healthy volunteers (n = 48), DM patients without retinopathy (n = 53) and with retinopathy (n = 29).

[Correlation of cutaneous blood microcirculation parameters with biological age in diabetic patients.].

It has been established that the age together with the number of chronic diseases cause the decrease of the reactivity of the microcirculatory bed. This study aims to evaluate the relationship between cutaneous microcirculation parameters and biological and chronological age of patients with diabetes mellitus. 11 diabetic patients (median age 57 (51; 64) years) were examined in course of this study; biological age was figured by Aging.

Reduced microvascular reactivity in patients with diabetic neuropathy.

Background: Neurogenic regulation is involved in the development of microcirculation response to local heating. We suggest that microvascular reactivity can be used to estimate the severity of diabetic polyneuropathy (DPN).

Objective: To evaluate the prospects for using the parameters of skin microvascular reactivity to determine the severity of DPN.

Reactivity of skin microcirculation as a biomarker of cardiovascular events. Pilot study.

Background: The role of microcirculatory disorders is progressively being accepted in the pathogenesis of cardiovascular diseases.

Objective: The purpose of current study is to assess whether we can consider skin microcirculation disorders as a biomarker of cardiovascular events.

Methods: Group 1 consisted of healthy volunteers (n = 31); group 2 (n = 42) consisted of patients with diseases that increase the risk of cardiovascular events; group 3 (n = 39) included patients with the history of cardiovascular events.